-
Apollo Hospitals
6,900.70 5,690.80(%) -
Waaree Energies
2,590.20 1,808.65(%) -
Reliance Industr
1,288.00 1,115.55(%) -
SpiceJet
55.49 79.90(%) -
Axis Bank
1,145.75 934.00(%) -
Dixon Technolog.
16,092.55 7,772.55(%) -
Suzlon Energy
56.78 37.95(%) -
Vodafone Idea
7.44 6.60(%) -
SBI Life Insuran
1,763.00 1,935.00(%) -
Tata Motors
651.45 542.55(%) -
Bharat Electron
293.70 221.00(%) -
Tata Power Co.
382.00 326.25(%) -
Reliance Power
40.91 23.26(%) -
Eternal Ltd
226.95 146.85(%) -
HDFC Bank
1,891.90 1,430.15(%) -
Jio Financial
249.15 198.60(%) -
Mazagon Dock
2,585.00 1,046.00(%) -
Adani Energy Sol
907.00 588.25(%) -
Nip. India Nifty
266.61 242.12(%) -
Adani Green
904.00 758.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Laurus Labs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 45955.0
- ISIN : INE947Q01028
-
Today’s Low
606.50 -
Today’s High
643.35

-
Open
630.00 -
Perv Close
645.50 -
52W Low
385.45 -
52W High
660.90
Key Indicators
-
P/E(TTM)
88.71
-
Mar.Cap (₹Cr.)
33,738.33
-
Div & Yield %
0.13
-
Book Value(₹)
84.63
-
Debt-Equity Ratio
-3.08
-
AGM Date
25-Apr-2025
-
EPS
7.05
-
P/E Ratio
88.71
Financials Ratios
-
Debt-Equity Ratio
0.56
-
Mar.Cap (₹Cr.)
33,738.33
-
RONW (%)
4.13
-
ROCE (%)
6.31
Score Board
-
Equity (₹ in Cr.)
107.85
-
BV (₹)
79.20
-
Sales( ₹ in Cr.)
4,812.39
-
NP (in Cr.)
224.27
-
NP Var(%)
-71.0
-
Div%
40.0
-
CPS (₹)
10.60
-
EPS (₹)
4.20
-
Traded Value (₹ in Lakhs)
34,897.72
-
52 Week High
660.90
-
52 Week Low
385.45
-
Price BSE
647.0
-
Price NSE
646.00
-
Market Capital( in Cr.)
34,897.72
-
P/C Ratio
61.30
-
P/E Ratio
155.60
-
Price Vs.BV
4.20
-
24-Apr-2025( 05:20)
Hot Pursuit - Lauru... - Revenue from operations jumped...
-
24-Apr-2025( 04:52)
Corporate News - Board... - Laurus Labs announced that th...
-
24-Apr-2025( 04:24)
Results - Announcements - Lauru... - Net profit of Laurus Labs rose...
-
11-Apr-2025( 09:55)
Corporate News - Lauru... - Laurus Labs will hold a meeti...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 4,812.39 | 5,773.45 | 4,707.04 | 4,768.72 | 2,797.34 | 2,236.15 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 4,812.39 | 5,773.45 | 4,707.04 | 4,768.72 | 2,797.34 | 2,236.15 |
Other Income | 47.42 | 15.95 | 21.55 | 27.32 | 5.81 | 16.13 |
Stock Adjustments | 102.48 | -40.82 | 218.62 | 296.45 | 218.09 | 28.92 |
Total Income | 4,962.29 | 5,748.58 | 4,947.21 | 5,092.49 | 3,021.24 | 2,281.20 |
EXPENDITURE : | ||||||
Raw Materials | 2,507.87 | 2,671.65 | 2,427.18 | 2,471.58 | 1,620.64 | 1,237.85 |
Power and Fuel Cost | 309.67 | 301.10 | 188.52 | 149.69 | 132.62 | 105.50 |
Employee Cost | 531.93 | 477.88 | 417.57 | 364.83 | 299.90 | 256.85 |
Other Manufacturing Expenses | 491.94 | 431.99 | 326.34 | 298.12 | 191.38 | 151.49 |
Selling and Administration Expenses | 293.96 | 323.95 | 265.52 | 260.60 | 190.04 | 145.00 |
Miscellaneous Expenses | 29.62 | 44.30 | 15.33 | 10.48 | 10.62 | 16.92 |
Employee Benefit Expenses | 531.93 | 477.88 | 417.57 | 364.83 | 299.90 | 256.85 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 4,164.99 | 4,250.87 | 3,640.46 | 3,555.30 | 2,445.20 | 1,913.61 |
Operating Profit | 797.30 | 1,497.71 | 1,306.75 | 1,537.19 | 576.04 | 367.58 |
Interest | 150.82 | 145.70 | 95.86 | 65.92 | 87.71 | 85.83 |
Gross Profit | 646.48 | 1,352.01 | 1,210.89 | 1,471.27 | 488.33 | 281.75 |
Depreciation | 345.01 | 300.58 | 235.48 | 196.64 | 183.85 | 160.53 |
Profit Before Tax | 301.47 | 1,051.43 | 975.41 | 1,274.63 | 304.48 | 121.22 |
Current Tax | 87.94 | 270.78 | 231.42 | 334.98 | 53.00 | 24.83 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -10.17 | 20.27 | -6.10 | -16.46 | -15.57 | 1.39 |
Reported Net Profit | 223.70 | 760.38 | 750.09 | 956.11 | 267.05 | 94.99 |
Extraordinary Items | -0.57 | -0.14 | -0.85 | -0.63 | -0.67 | -0.62 |
Adjusted Net Profit | 224.27 | 760.52 | 750.94 | 956.74 | 267.72 | 95.61 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | -3.50 | -3.27 |
P & L Balance brought forward | 3,230.09 | 2,577.18 | 1,912.95 | 1,031.88 | 803.63 | 727.81 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 86.18 | 107.47 | 85.86 | 75.04 | 35.30 | 15.90 |
P & L Balance carried down | 3,367.61 | 3,230.09 | 2,577.18 | 1,912.95 | 1,031.88 | 803.63 |
Dividend | 86.18 | 107.47 | 85.86 | 75.04 | 16.04 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 40.00 | 100.00 | 100.00 | 100.00 | 25.00 | 15.00 |
Dividend Per Share(Rs) | 0.80 | 2.00 | 2.00 | 2.00 | 2.50 | 1.50 |
Earnings Per Share-Unit Curr | 4.15 | 14.12 | 13.96 | 17.82 | 24.98 | 8.92 |
Earnings Per Share(Adj)-Unit Curr | 4.15 | 14.12 | 13.96 | 17.82 | 5.00 | 1.78 |
Book Value | 78.06 | 75.31 | 63.05 | 50.54 | 169.84 | 149.47 |
Book Value(Adj)-Unit Curr | 78.06 | 75.31 | 63.05 | 50.54 | 33.97 | 29.89 |